True Wealth Design, LLC Black Diamond Therapeutics, Inc. Transaction History
True Wealth Design, LLC
- $263 Billion
- Q1 2025
A detailed history of True Wealth Design, LLC transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, True Wealth Design, LLC holds 27 shares of BDTX stock, worth $58. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27Holding current value
$58% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BDTX
# of Institutions
94Shares Held
41.1MCall Options Held
45.1KPut Options Held
37K-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.4MShares$22.6 Million0.01% of portfolio
-
Vestal Point Capital, LP New York, NY5.6MShares$12.2 Million0.62% of portfolio
-
Nea Management Company, LLC Timonium, MD4.45MShares$9.65 Million0.65% of portfolio
-
Black Rock Inc. New York, NY3.22MShares$6.98 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.73MShares$5.93 Million0.1% of portfolio
About Black Diamond Therapeutics, Inc.
- Ticker BDTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,339,500
- Market Cap $78.9M
- Description
- Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...